Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Virtual Reality Distraction for Oocyte Retrieval
NCT05244538Completed
- Sponsor
- Erasmus Hospital
- Start
- Feb 2022
- Primary completion
- Apr 2022
- Countries
- 1
01
Overview
Randomised, open-label trial, sponsored by Erasmus Hospital. Primary endpoint: Dose reduction in propofol and remifentanil requirements at 2 hours. Started Feb 2022; status: completed.
Beyond the preview
Go deeper on NCT05244538.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05244538.